CA2024-LM-001: Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases (clinicaltrials.gov) - Sep 10, 2026 - P1/2 | N=24 | Recruiting | Sponsor: Cerenome | Phase classification: P1 ➔ P1/2
Phase classification • Oncology • Solid Tumor
|